Cargando…

A Randomized Controlled Trial of the Effect of 0.01% Atropine Eye Drops Combined with Auricular Acupoint Stimulation on Myopia Progression

BACKGROUND: Use of 0.01% atropine eye drops (0.01% A) is one of the most common treatments for myopia control for children in Asia. Auricular acupoint stimulation (AAS) was reported to enhance the effect of higher-concentration atropine (0.25%, 0.125%) on myopia control. This study was designed to c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Xie-He, Zhao, Yue, Chen, Zhi, Zeng, Li, Han, Rong, Dong, Xiao-Qing, Guo, Xiao-Cong, Shi, Zheng, Yang, Guang, Yang, Yan-Ting, Zhang, Dan, Zhou, Xing-Tao, Ma, Xiao-Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373503/ https://www.ncbi.nlm.nih.gov/pubmed/34422405 http://dx.doi.org/10.1155/2021/5585441

Ejemplares similares

Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023)

Comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Jethani, Jitendra, et al.
Publicado: (2020)

Atropine 0.01% Eye Drops for Myopia Control in American Children: A Multiethnic Sample Across Three US Sites
por: Larkin, G. Luke, et al.
Publicado: (2019)

The Effect of 0.01% Atropine Eye Drops on the Ocular Surface in Children for the Control of Myopia—The Primary Results from a Six-Month Prospective Study
por: Cheng, Jingyi, et al.
Publicado: (2020)

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020)

Response to comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2020)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021)

Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children
por: Jethani, Jitendra, et al.
Publicado: (2021)

Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Patil, Ankita A, et al.
Publicado: (2022)

Compounded 0.01% Atropine—What's in the Bottle?
por: Richdale, Kathryn, et al.
Publicado: (2023)

Effectiveness of 0.01% atropine in anisomyopic children
por: Hussain, Azfira, et al.
Publicado: (2023)

Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
por: Ye, Luyao, et al.
Publicado: (2022)

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
por: Li, Huixia, et al.
Publicado: (2022)

A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
por: Joachimsen, Lutz, et al.
Publicado: (2019)

Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia
por: Kothari, Mihir, et al.
Publicado: (2020)

Response to comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety
por: Hansen, Niklas Cyril, et al.
Publicado: (2023)

Low-Concentration Atropine Eye Drops for Myopia Progression
por: Li, Fen Fen, et al.
Publicado: (2019)

Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
por: Erdinest, Nir, et al.
Publicado: (2022)

The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis
por: Wang, Zengying, et al.
Publicado: (2023)

Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial
por: Yuan, Ying, et al.
Publicado: (2021)

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial
por: Cui, Can, et al.
Publicado: (2021)

Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study
por: Du, Linlin, et al.
Publicado: (2023)

Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population
por: Chaurasia, Shweta, et al.
Publicado: (2022)

Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%
por: Rose, Loreto V. T., et al.
Publicado: (2021)

The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
por: Cheng, Ziyun, et al.
Publicado: (2021)

Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response
por: Chan, Henry H. L., et al.
Publicado: (2022)

The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis
por: Gao, Yue, et al.
Publicado: (2022)

Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
por: Yu, Manrong, et al.
Publicado: (2023)

Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2023)

Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
por: Lee, Lung-Chi, et al.
Publicado: (2022)

Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study
por: Joachimsen, Lutz, et al.
Publicado: (2021)

Allergic reactions to atropine eye drops for retardation of progressive myopia in children
por: Kothari, Mihir, et al.
Publicado: (2018)

Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report
por: Yan, Chunxiao, et al.
Publicado: (2023)

Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes
por: Kothari, Mihir, et al.
Publicado: (2017)

Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial
por: Zadnik, Karla, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ijnct18d2aq65tn444kbc68654